Immunscape is a privately-held drug discovery company based in Stockholm, Sweden. Founded in 2016, Immunscape is focused on the development of immunotherapies for the treatment of cancer and autoimmune diseases. Immunscape has a team with a proven track record of success in bringing small molecules from discovery phase to the clinic.
| Website | http://immunscape.com/ |
| Revenue | $5 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2016 |
| Technologies |
JavaScript
,
HTML
,
PHP
+7 more
(view full list)
|
| Industry | Biotechnology, Manufacturing General, Manufacturing |
| Keywords | Immunotherapy, Drug Discovery, Cancer Treatment, Autoimmune Diseases, Biotechnology, Pharmaceutical, Clinical Trials, Immunology Research, Precision Medicine, Therapeutics, Biopharma, Drug Development, Healthcare, Life Sciences, Biotechnology Research, Medical Research, Oncology, Immunomodulation, Cell Therapy, Clinical Stage |
| Competitors | GSK, Moderna Therapeutics, Novavax, CureVac, INOVIO Pharmaceuticals, Inc., Valo, Vaxart, Inc., AEON Biopharma, Inc., Rational Vaccines, IMMUNOVACCINE TECHNOLOGIES +40 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Immunscape employee's phone or email?
Immunscape Questions
The Immunscape annual revenue was $5 million in 2026.
The NAICS codes for Immunscape are [32, 325, 3254, 32541].
The SIC codes for Immunscape are [28, 283].
Related Companies
G2Crowd Trusted
300K+
Plugin Users
